|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5728553A
(en)
*
|
1992-09-23 |
1998-03-17 |
Delta Biotechnology Limited |
High purity albumin and method of producing
|
|
DE19538625C2
(de)
*
|
1995-10-17 |
1999-08-12 |
Sartorius Gmbh |
Verfahren zur Abtrennung von Albumin aus Serum durch Membranionenaustauschchromatographie
|
|
GB9526733D0
(en)
*
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
|
DK0889949T3
(da)
*
|
1996-03-13 |
2003-09-22 |
Delta Biotechnology Ltd |
Fermenteringskontrol
|
|
GB9902000D0
(en)
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
|
AU2007200859A1
(en)
*
|
1999-01-30 |
2007-03-22 |
Novozymes Delta Limited |
Process
|
|
FR2792650B1
(fr)
*
|
1999-04-20 |
2003-02-28 |
Oreal |
Equivalent de peau agee, son procede de preparation et son utilisation
|
|
EP1586329A1
(en)
*
|
2000-02-08 |
2005-10-19 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions
|
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
|
US8632785B2
(en)
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
|
US20060269575A1
(en)
*
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
|
US20050100991A1
(en)
*
|
2001-04-12 |
2005-05-12 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
JP2003530838A
(ja)
*
|
2000-04-12 |
2003-10-21 |
ヒューマン ゲノム サイエンシズ インコーポレイテッド |
アルブミン融合タンパク質
|
|
CA2774959C
(en)
*
|
2000-08-04 |
2016-05-31 |
Dmi Biosciences, Inc. |
Method of using diketopiperazines and composition containing them
|
|
JP4798833B2
(ja)
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
加熱処理工程を含むヒト血清アルブミンの製造方法
|
|
ATE331735T1
(de)
*
|
2000-10-24 |
2006-07-15 |
Chemo Sero Therapeut Res Inst |
Verfahren zur monomerisierung von humanen serumalbumin-polymeren
|
|
JP4798832B2
(ja)
*
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
ヒト血清アルブミン多量体の除去方法
|
|
US7507413B2
(en)
*
|
2001-04-12 |
2009-03-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US20050054051A1
(en)
*
|
2001-04-12 |
2005-03-10 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
WO2002101021A2
(en)
*
|
2001-06-13 |
2002-12-19 |
Taurus Hsa Llc |
Purification of human serum albumin
|
|
ITBO20010426A1
(it)
*
|
2001-07-06 |
2003-01-06 |
Alfa Wassermann Spa |
Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
|
|
JP2003040798A
(ja)
*
|
2001-07-26 |
2003-02-13 |
Nihon Pharmaceutical Co Ltd |
低アルミニウム含有アルブミン製剤およびその製造法
|
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
US7998986B2
(en)
*
|
2001-12-21 |
2011-08-16 |
Exelixis Patent Company Llc |
Modulators of LXR
|
|
US20080167238A1
(en)
*
|
2001-12-21 |
2008-07-10 |
Human Genome Sciences, Inc. |
Albumin Fusion Proteins
|
|
ES2425738T3
(es)
*
|
2001-12-21 |
2013-10-17 |
Human Genome Sciences, Inc. |
Proteínas de fusión de la albúmina
|
|
AU2002364587A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
GB0217033D0
(en)
|
2002-07-23 |
2002-08-28 |
Delta Biotechnology Ltd |
Gene and polypeptide sequences
|
|
US7575929B2
(en)
*
|
2002-10-02 |
2009-08-18 |
Dmi Life Sciences, Inc. |
Diagnosis of multiple sclerosis with diketopiperazines
|
|
EP1594530A4
(en)
|
2003-01-22 |
2006-10-11 |
Human Genome Sciences Inc |
HYBRID PROTEINS OF ALBUMIN
|
|
CN103191409A
(zh)
|
2003-05-15 |
2013-07-10 |
Dmi生物科学公司 |
T-细胞介导的疾病的治疗
|
|
US8013611B2
(en)
*
|
2006-07-14 |
2011-09-06 |
Reserve Power Cell, Llc |
Vehicle battery product and battery monitoring system
|
|
US7339347B2
(en)
*
|
2003-08-11 |
2008-03-04 |
Reserve Power Cell, Llc |
Apparatus and method for reliably supplying electrical energy to an electrical system
|
|
GB0329722D0
(en)
*
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Modified plasmid and use thereof
|
|
GB0329681D0
(en)
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Gene expression technique
|
|
RU2006128593A
(ru)
*
|
2004-01-07 |
2008-02-20 |
Тримерис, Инк. (Us) |
Синтетические пептиды, производные области hr2 белка gp41 вич, и их применение в терапии для ингибирования проникновения вируса иммунодефицита человека
|
|
WO2005068489A1
(ja)
|
2004-01-20 |
2005-07-28 |
Juridical Foundation The Chemo-Sero Therapeutic Research Institute |
２価陽イオン存在下加熱処理によるヒト血清アルブミンの製造方法
|
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
|
JP5631533B2
(ja)
|
2004-12-23 |
2014-11-26 |
ノボザイムス バイオファーマ デーコー アクティーゼルスカブ |
遺伝子発現技術
|
|
US20060199280A1
(en)
*
|
2005-03-03 |
2006-09-07 |
David Bar-Or |
Quantification of proteins
|
|
US7598700B2
(en)
*
|
2005-03-30 |
2009-10-06 |
Reserve Power Cell, Llc |
Tamper resistant battery and battery warranty and performance tracking system
|
|
MY144344A
(en)
*
|
2005-04-08 |
2011-09-15 |
Ciba Holding Inc |
Adsorbents comprising anthraquinone dye-ligands for the separation of biological materials
|
|
DE102005023155A1
(de)
*
|
2005-05-13 |
2006-11-16 |
Albutec Gmbh |
Albuminlösung
|
|
US8323666B2
(en)
|
2005-08-01 |
2012-12-04 |
Allergan, Inc. |
Botulinum toxin compositions
|
|
GB0518460D0
(en)
*
|
2005-09-09 |
2005-10-19 |
Univ Nottingham Trent |
Protein assay
|
|
EP1989220B1
(en)
|
2006-02-02 |
2011-12-14 |
Trimeris, Inc. |
Hiv fusion inhibitor peptides with improved biological properties
|
|
JP2007284425A
(ja)
*
|
2006-03-20 |
2007-11-01 |
Nokodai Tlo Kk |
タンパク質の精製方法
|
|
BRPI0712383A2
(pt)
*
|
2006-06-07 |
2012-07-10 |
Human Genome Sciences Inc |
proteìnas de fusão da albumina
|
|
AU2007274035A1
(en)
*
|
2006-07-13 |
2008-01-17 |
Novozymes Biopharma Dk A/S |
Process for preparing particles of proteinaceous material
|
|
ATE524493T1
(de)
|
2006-07-24 |
2011-09-15 |
Biorexis Pharmaceutical Corp |
Exendin-fusionsproteine
|
|
US10829733B2
(en)
*
|
2007-01-04 |
2020-11-10 |
Biolamina Ab |
Composition and method for enabling proliferation of pluripotent human stem cells
|
|
KR20100016142A
(ko)
*
|
2007-04-03 |
2010-02-12 |
트라이머리스, 인코퍼레이티드 |
항바이러스 펩티드 치료제 전달용 신규 제제
|
|
CN101104635B
(zh)
*
|
2007-04-30 |
2010-11-03 |
北京济普霖生物技术有限公司 |
一种从转基因牛乳中纯化重组人α-乳清白蛋白的方法
|
|
EP2201036A1
(en)
*
|
2007-08-08 |
2010-06-30 |
Novozymes Biopharma DK A/S |
Transferrin variants and conjugates
|
|
KR20100080812A
(ko)
*
|
2007-09-25 |
2010-07-12 |
트라이머리스, 인코퍼레이티드 |
치료용 항-ｈｉｖ 펩티드의 합성 방법
|
|
US8445213B2
(en)
*
|
2008-03-31 |
2013-05-21 |
Sekisui Medical Co., Ltd. |
Purified serum albumin, and immunological measurement method
|
|
KR20110020819A
(ko)
*
|
2008-05-15 |
2011-03-03 |
가부시키가이샤 아루떼꾸 우에노 |
안구건조증 및/또는 각막/결막 질환 치료용 약학 조성물
|
|
US8217047B2
(en)
*
|
2008-05-27 |
2012-07-10 |
Dmi Acquisition Corp. |
Therapeutic methods and compounds
|
|
CA2729322C
(en)
|
2008-06-24 |
2020-05-26 |
Technische Universitaet Muenchen |
Muteins of hngal and related proteins with affinity for a given target
|
|
SG172789A1
(en)
|
2009-02-11 |
2011-08-29 |
Novozymes Biopharma Dk As |
Albumin variants and conjugates
|
|
SG173469A1
(en)
*
|
2009-02-20 |
2011-09-29 |
Ventria Bioscience |
Cell culture media containing combinations of proteins
|
|
DE102009013914B4
(de)
*
|
2009-03-19 |
2011-05-05 |
Bruker Daltonik Gmbh |
Kalibriersubstanzen für Atmosphärendruck-Ionenquellen
|
|
EP2427486B1
(en)
*
|
2009-05-07 |
2015-02-25 |
Novozymes Biopharma DK A/S |
Method for purifying albumin
|
|
BR112012002709A2
(pt)
|
2009-08-05 |
2019-04-30 |
Pieris Ag |
formulações de liberação controlada de muteínas de lipocalina
|
|
WO2011022657A1
(en)
*
|
2009-08-20 |
2011-02-24 |
Baxter International Inc. |
Purification of vwf for increased removal of non-lipid enveloped viruses
|
|
BR112012009450A2
(pt)
|
2009-10-30 |
2017-05-23 |
Novozymes Biopharma Dk As |
variantes de albumina
|
|
EP3660510A3
(en)
|
2009-12-07 |
2020-07-08 |
Pieris Pharmaceuticals GmbH |
Muteins of human lipocalin 2 (lcn2, hngal) with affinity for a given target
|
|
CA2787942A1
(en)
*
|
2010-01-25 |
2011-07-28 |
Ventria Bioscience |
Methods & compositions for improving protein production
|
|
EP2556087A1
(en)
|
2010-04-09 |
2013-02-13 |
Novozymes Biopharma DK A/S |
Albumin derivatives and variants
|
|
US8986951B2
(en)
|
2010-06-08 |
2015-03-24 |
Pieris Ag |
Tear lipocalin in muteins binding IL-4 R alpha
|
|
CA2808392C
(en)
|
2010-08-16 |
2020-03-10 |
Pieris Pharmaceuticals Gmbh |
Binding proteins for hepcidin
|
|
CA2810844C
(en)
|
2010-09-07 |
2017-03-21 |
Dmi Acquisition Corp. |
Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
|
|
EP2640740B1
(en)
|
2010-11-15 |
2017-03-15 |
Pieris Pharmaceuticals GmbH |
Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
|
|
DK2646552T3
(en)
|
2010-12-02 |
2017-10-23 |
Pieris Pharmaceuticals Gmbh |
MUTEINES OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR CTLA-4
|
|
PL221899B1
(pl)
|
2011-05-06 |
2016-06-30 |
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną |
Czysta albumina oraz sposób jej otrzymywania i detekcji
|
|
SG10201606161UA
(en)
|
2011-07-05 |
2016-09-29 |
Novozymes Biopharma Dk As |
Albumin Formulation and Use
|
|
EP2765968A4
(en)
|
2011-10-10 |
2015-01-21 |
Ampio Pharmaceuticals Inc |
IMPLANTABLE MEDICINE PRODUCTS WITH INCREASED IMMUNO TOLERANCE AND PROCESSING AND IMPLANTATION METHODS
|
|
CA2846598C
(en)
|
2011-10-10 |
2019-12-10 |
Ampio Pharmaceuticals, Inc. |
Treatment of degenerative joint disease
|
|
HK1198812A1
(en)
|
2011-10-28 |
2015-06-12 |
Ampio Pharmaceuticals, Inc. |
Treatment of rhinitis
|
|
EP2780364A2
(en)
|
2011-11-18 |
2014-09-24 |
Eleven Biotherapeutics, Inc. |
Proteins with improved half-life and other properties
|
|
ES2863410T3
(es)
|
2011-12-13 |
2021-10-11 |
Pieris Pharmaceuticals Gmbh |
Métodos para prevenir o tratar ciertos trastornos mediante la inhibición de la unión de IL-4 y/o IL-13 a sus respectivos receptores.
|
|
ES2664328T3
(es)
|
2012-03-16 |
2018-04-19 |
Albumedix A/S |
Variantes de albúmina
|
|
WO2013174783A1
(en)
|
2012-05-23 |
2013-11-28 |
Pieris Ag |
Lipocalin muteins with binding-affinity for glypican-3 (gpc-3) and use of lipocalin muteins for target-specific delivery to cells expressing gpc-3
|
|
US20140031527A1
(en)
*
|
2012-07-27 |
2014-01-30 |
Csl Limited |
Method for polishing albumin
|
|
CA2890766A1
(en)
|
2012-11-08 |
2014-05-15 |
Novozymes Biopharma Dk A/S |
Albumin variants
|
|
US20140186447A1
(en)
*
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
JP6128677B2
(ja)
*
|
2013-02-05 |
2017-05-17 |
公立大学法人大阪市立大学 |
神経細胞の遊走障害を伴う疾患の判定方法及びその利用
|
|
EP2968490A1
(en)
|
2013-03-14 |
2016-01-20 |
Daiichi Sankyo Co., Ltd. |
Novel binding proteins for pcsk9
|
|
EA201500943A1
(ru)
|
2013-03-15 |
2016-08-31 |
Ампио Фармасьютикалс, Инк. |
Составы для мобилизации, хоуминга, размножения и дифференцировки стволовых клеток и способы применения составов
|
|
CA2891557A1
(en)
|
2013-03-26 |
2014-05-22 |
Pieris Ag |
Novel specific-binding polypeptides and uses thereof
|
|
CN103694343B
(zh)
*
|
2013-12-26 |
2016-05-25 |
扬州艾迪生物科技有限公司 |
一种从尿液中制备人血白蛋白的方法
|
|
WO2015104406A2
(en)
|
2014-01-13 |
2015-07-16 |
Pieris Ag |
Multi-specific polypeptide useful for localized tumor immunomodulation
|
|
EP4147761A1
(en)
*
|
2014-04-30 |
2023-03-15 |
Novo Nordisk A/S |
Methods for the purification of proteins using caprylic acid
|
|
SG10201912019WA
(en)
|
2014-05-22 |
2020-02-27 |
Pieris Pharmaceuticals Gmbh |
Novel specific-binding polypeptides and uses thereof
|
|
CA2958080A1
(en)
|
2014-08-18 |
2016-02-25 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
|
CN104628830A
(zh)
*
|
2015-01-23 |
2015-05-20 |
深圳康泰生物制品股份有限公司 |
重组酿酒酵母表达HBsAg的制备工艺及其分离纯化工艺、HBsAg和乙肝疫苗
|
|
AU2016212087B2
(en)
|
2015-01-28 |
2019-11-07 |
Pieris Pharmaceuticals Gmbh |
Novel proteins specific for angiogenesis
|
|
BR112017017530A2
(pt)
|
2015-02-18 |
2018-04-17 |
Sanofi |
proteínas específicas para pioverdina e pioquelina
|
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
|
RU2736312C2
(ru)
|
2015-05-04 |
2020-11-13 |
ПИЕРИС ФАРМАСЬЮТИКАЛС ГмбХ |
Белки, специфичные в отношении cd137
|
|
AU2016258977C1
(en)
|
2015-05-04 |
2022-07-14 |
Pieris Pharmaceuticals Gmbh |
Anti-cancer fusion polypeptide
|
|
US10273275B2
(en)
|
2015-05-18 |
2019-04-30 |
Pieris Pharmaceuticals Gmbh |
Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof
|
|
AU2016262845B2
(en)
|
2015-05-18 |
2020-07-23 |
Pieris Pharmaceuticals Gmbh |
Anti-cancer fusion polypeptide
|
|
US11389512B2
(en)
|
2015-06-22 |
2022-07-19 |
Ampio Pharmaceuticals, Inc. |
Use of low molecular weight fractions of human serum albumin in treating diseases
|
|
EP3115371A1
(en)
|
2015-07-07 |
2017-01-11 |
Sanofi |
Fusion molecules
|
|
KR20180029238A
(ko)
|
2015-07-15 |
2018-03-20 |
피어이스 파마슈티컬즈 게엠베하 |
Lag-3에 특이적인 신규 단백질
|
|
CA2989966C
(en)
|
2015-08-20 |
2024-04-30 |
Albumedix A/S |
Albumin variants and conjugates
|
|
FR3040882A1
(fr)
*
|
2015-09-10 |
2017-03-17 |
Lab Francais Du Fractionnement |
Composition liquide d'albumine humaine a usage therapeutique
|
|
EA035586B1
(ru)
|
2015-11-30 |
2020-07-10 |
Пиерис Острелиа Пти Лтд. |
Новые антиангиогенные слитые белки
|
|
TW201725212A
(zh)
|
2015-12-10 |
2017-07-16 |
第一三共股份有限公司 |
特異性於降鈣素基因相關胜肽的新穎蛋白
|
|
CN108431204A
(zh)
|
2015-12-22 |
2018-08-21 |
阿尔布梅迪克斯医疗有限公司 |
改良的表达蛋白质的菌株
|
|
JP7146637B2
(ja)
|
2015-12-22 |
2022-10-04 |
アルブミディクス リミティド |
改善されたタンパク質発現株
|
|
KR102050852B1
(ko)
*
|
2016-03-11 |
2019-12-03 |
주식회사 스템온 |
세포 리프로그래밍 장치
|
|
AU2017313268C1
(en)
*
|
2016-08-17 |
2024-10-10 |
Boehringer Ingelheim International Gmbh |
Process for the preparation of highly concentrated liquid formulations containing biomolecules
|
|
EP3429345B1
(en)
|
2016-10-04 |
2019-09-11 |
Albumedix Ltd. |
Uses of recombinant yeast-derived serum albumin
|
|
WO2018087108A1
(en)
|
2016-11-09 |
2018-05-17 |
Pieris Pharmaceuticals Gmbh |
Proteins specific for cd137
|
|
WO2018134274A1
(en)
|
2017-01-18 |
2018-07-26 |
Pieris Pharmaceuticals Gmbh |
Lipocalin muteins with binding affinity for lag-3
|
|
CA3058234A1
(en)
*
|
2017-03-16 |
2018-09-20 |
Therapure Biopharma Inc. |
Method for purification of albumin
|
|
CA3064037A1
(en)
|
2017-06-20 |
2018-12-27 |
Albumedix Ltd |
Improved protein expression strains
|
|
CN110563833A
(zh)
*
|
2018-06-06 |
2019-12-13 |
中国计量科学研究院 |
一种人血白蛋白标准物质原料的制备方法及其产品和应用
|
|
HRP20230590T2
(hr)
|
2018-07-31 |
2024-02-16 |
Pieris Pharmaceuticals Gmbh |
Novi fuzijski protein specifičan za cd137 i pd-l1
|
|
CN109734796B
(zh)
*
|
2019-02-01 |
2022-04-15 |
广州蕊特生物科技有限公司 |
一种从溶血血清中分离白蛋白的工艺
|
|
CN109776673B
(zh)
*
|
2019-02-20 |
2022-03-29 |
天津理工大学 |
一种适合中试量产的高纯度牛血清白蛋白纯化工艺
|
|
JP7476219B2
(ja)
|
2019-02-26 |
2024-04-30 |
ピエリス ファーマシューティカルズ ゲーエムベーハー |
Ｃｄ１３７およびｇｐｃ３に特異的な新規融合タンパク質
|
|
CN110229229A
(zh)
*
|
2019-07-10 |
2019-09-13 |
甘肃养泰和生物科技有限公司 |
一种从牛血浆中提取纯化细胞培养级牛血清白蛋白的生产方法及其应用
|
|
WO2021086946A1
(en)
|
2019-10-28 |
2021-05-06 |
Abraxis Bioscience, Llc |
Pharmaceutical compositions of albumin and rapamycin
|
|
JP2023527908A
(ja)
|
2020-06-05 |
2023-06-30 |
ピエリス ファーマシューティカルズ ゲーエムベーハー |
４－１ｂｂをターゲティングする多量体免疫調節物質
|
|
US12161777B2
(en)
|
2020-07-02 |
2024-12-10 |
Davol Inc. |
Flowable hemostatic suspension
|
|
US11739166B2
(en)
|
2020-07-02 |
2023-08-29 |
Davol Inc. |
Reactive polysaccharide-based hemostatic agent
|
|
CN116390942A
(zh)
*
|
2020-08-11 |
2023-07-04 |
深圳普罗吉医药科技有限公司 |
年轻且无损伤的人血清白蛋白延长人类寿命
|
|
CN116406374A
(zh)
|
2020-10-30 |
2023-07-07 |
深圳普罗吉医药科技有限公司 |
人血清白蛋白在治疗疾病中的应用
|
|
WO2022120547A1
(zh)
|
2020-12-08 |
2022-06-16 |
通化安睿特生物制药股份有限公司 |
纯化重组蛋白的方法
|
|
CN112592399B
(zh)
*
|
2020-12-15 |
2024-04-12 |
甘肃养泰和生物科技有限公司 |
一种从牛血清中分离牛血清白蛋白的制备方法及装置
|
|
CN116744984A
(zh)
|
2020-12-28 |
2023-09-12 |
达沃有限公司 |
包含蛋白质和多官能化改性的基于聚乙二醇的交联剂的反应性干粉状止血材料
|
|
EP4320141A1
(en)
|
2021-04-08 |
2024-02-14 |
Pieris Pharmaceuticals GmbH |
Novel lipocalin muteins specific for connective tissue growth factor (ctgf)
|
|
WO2022243341A1
(en)
|
2021-05-18 |
2022-11-24 |
Pieris Pharmaceuticals Gmbh |
Lipocalin muteins with binding affinity for ox40
|
|
CN113735963A
(zh)
*
|
2021-09-10 |
2021-12-03 |
山东健通生物科技有限公司 |
一种重组人血清白蛋白纯化过程去除色素的方法
|
|
CN114316088B
(zh)
*
|
2021-12-22 |
2022-09-09 |
中国水产科学研究院黄海水产研究所 |
亲和树脂、制备方法及其在分离纯化藻蓝蛋白中的应用
|
|
TW202428603A
(zh)
|
2022-09-21 |
2024-07-16 |
美商思進公司 |
新穎的cd137及cd228特異性融合蛋白
|
|
CN115677848A
(zh)
|
2022-10-24 |
2023-02-03 |
通化安睿特生物制药股份有限公司 |
一种制备高纯度高稳定性蛋白质的方法
|
|
CN116120392B
(zh)
*
|
2023-04-18 |
2023-08-01 |
上海健士拜生物科技有限公司 |
聚体蛋白的纯化方法
|
|
WO2025175123A1
(en)
|
2024-02-16 |
2025-08-21 |
Seagen Inc. |
Methods of treating cancer using fusion proteins specific for cd137 and cd228
|